Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Kiniksa Pharmaceuticals, Ltd. (KNSA)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
4 Mar 2024
Patel Sanj K
CHAIRMAN & CEO, Director, Officer
Kiniksa Pharmaceuticals, Ltd.
(KNSA)
65,012
-21%
18,324
$21.34
$391,055.88
SELL
1 Mar 2024
Tessari Eben
CHIEF OPERATING OFFICER, Officer
Kiniksa Pharmaceuticals, Ltd.
(KNSA)
122,847
-0%
1,189
$22.03
$26,193.67
SELL
28 Feb 2024
Megna Michael R
CHIEF ACCOUNTING OFFICER, Officer
Kiniksa Pharmaceuticals, Ltd.
(KNSA)
17,588
-45%
14,785
$21.57
$318,881.12
SELL
27 Feb 2024
Paolini John F.
CHIEF MEDICAL OFFICER, Officer
Kiniksa Pharmaceuticals, Ltd.
(KNSA)
44,892
-18%
10,156
$21.03
$213,580.69
SELL
3 Jan 2024
Ragosa Mark
CHIEF FINANCIAL OFFICER, Officer
Kiniksa Pharmaceuticals, Ltd.
(KNSA)
15,632
-43%
12,000
$20.00
$240,000.00
SELL
2 Jan 2024
Megna Michael R
CHIEF ACCOUNTING OFFICER, Officer
Kiniksa Pharmaceuticals, Ltd.
(KNSA)
17,005
-49%
16,670
$19.17
$319,563.90
SELL
19 Dec 2023
Megna Michael R
CHIEF ACCOUNTING OFFICER, Officer
Kiniksa Pharmaceuticals, Ltd.
(KNSA)
17,005
-35%
9,316
$19.13
$178,215.08
SELL
1 Sep 2023
Paolini John F.
CHIEF MEDICAL OFFICER, Officer
Kiniksa Pharmaceuticals, Ltd.
(KNSA)
44,892
-0%
400
$17.53
$7,012.00
SELL
25 Jul 2023
Paolini John F.
CHIEF MEDICAL OFFICER, Officer
Kiniksa Pharmaceuticals, Ltd.
(KNSA)
65,710
-30%
29,000
$19.14
$555,160.06
SELL
29 Nov 2022
Quart Barry D
Director
Kiniksa Pharmaceuticals, Ltd.
(KNSA)
0
-100%
21,959
$16.15
$354,637.84
SELL
7 Nov 2022
Paolini John F.
CHIEF MEDICAL OFFICER, Officer
Kiniksa Pharmaceuticals, Ltd.
(KNSA)
36,335
-43%
28,357
$15.18
$430,459.28
SELL
8 Feb 2021
Patel Sanj K
Chairman & CEO, Director, Officer
Kiniksa Pharmaceuticals, Ltd.
(KNSA)
0
-100%
56,159
$23.05
$1,294,534.10
SELL
3 Feb 2021
Beetham Thomas W.
EVP & Chief Legal Officer, Officer
Kiniksa Pharmaceuticals, Ltd.
(KNSA)
297,523
-0%
2,477
$22.09
$54,716.93
SELL
9 Oct 2020
Patel Sanj K
Chairman & CEO, Director, Officer
Kiniksa Pharmaceuticals, Ltd.
(KNSA)
0
-100%
251,572
$21.02
$5,288,012.50
SELL
1 Jul 2020
Beetham Thomas W.
EVP & Chief Legal Officer, Officer
Kiniksa Pharmaceuticals, Ltd.
(KNSA)
2,855
-91%
29,589
$25.37
$750,678.06
SELL
10 Jun 2020
Beetham Thomas W.
EVP & Chief Legal Officer, Officer
Kiniksa Pharmaceuticals, Ltd.
(KNSA)
29,589
-31%
13,752
$25.07
$344,762.62
SELL
20 Apr 2020
Beetham Thomas W.
EVP & Chief Legal Officer, Officer
Kiniksa Pharmaceuticals, Ltd.
(KNSA)
30,544
-62%
49,941
$19.10
$953,974.80
SELL
6 Mar 2020
Patel Sanj K
Chairman & CEO, Director, Officer
Kiniksa Pharmaceuticals, Ltd.
(KNSA)
212,570
-13%
33,115
$20.00
$662,300.00
SELL
19 Feb 2020
Paolini John F.
SVP & Chief Medical Officer, Officer
Kiniksa Pharmaceuticals, Ltd.
(KNSA)
19,116
-62%
32,280
$18.48
$596,487.10
SELL
14 Feb 2020
Beetham Thomas W.
EVP & Chief Legal Officer, Officer
Kiniksa Pharmaceuticals, Ltd.
(KNSA)
79,530
-0%
59
$18.58
$1,096.22
SELL
13 Feb 2020
Paolini John F.
SVP & Chief Medical Officer, Officer
Kiniksa Pharmaceuticals, Ltd.
(KNSA)
18,000
-38%
11,316
$18.29
$207,011.22
BUY
29 May 2018
Flynn James E
10% Owner, *Possible member of 10% group
Kiniksa Pharmaceuticals, Ltd.
(KNSA)
333,333
+165%
843,352
$18.97
$15,996,835.00
BUY
29 May 2018
Cormorant Asset Management, LP
10% Owner
Kiniksa Pharmaceuticals, Ltd.
(KNSA)
900,443
+8%
69,444
$18.00
$1,249,992.00
BUY
9 Feb 2018
BAKER BROS. ADVISORS LP
Director, 10% Owner
Kiniksa Pharmaceuticals, Ltd.
(KNSA)
299,403
+111%
3,000,000
$18.00
$54,000,000.00
Home